An open label randomized phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227) Meeting Abstract
| Authors: | Hellmann, M.; Ramalingam, S.; Reck, M.; O'Byrne, K.; Paz-Ares, L.; Harbison, C. T.; Bhagavatheeswaran, P.; Nathan, F.; Brahmer, J. |
| Abstract Title: | An open label randomized phase III trial of nivolumab or nivolumab plus ipilimumab vs platinum doublet chemotherapy (PT-DC) in patients with chemotherapy-naïve stage IV or recurrent non-small cell lung cancer (NSCLC) (CheckMate 227) |
| Meeting Title: | 30th Annual Scientific Meeting of the Society for Immunotherapy of Cancer (SITC 2015) |
| Journal Title: | Journal for ImmunoTherapy of Cancer |
| Volume: | 3 |
| Issue: | Suppl. 2 |
| Meeting Dates: | 2015 Nov 4-8 |
| Meeting Location: | National Harbor, MD |
| ISSN: | 2051-1426 |
| Publisher: | Biomed Central Ltd |
| Date Published: | 2015-11-04 |
| Language: | English |
| DOI: | 10.1186/2051-1426-3-S2-P154 |
| PROVIDER: | manual |
| PMCID: | PMC4645462 |
| Notes: | Meeting Abstract: P154 |
